ZEN Graphene Solutions Ltd. , a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce the 2021 Shareholder Meeting will be held on Monday, September 27th at 4pm at the Delta Hotel in Guelph, Ontario. Due to COVID-19, capacity will be limited to the first 50 shareholders who register by email at [...]
ZEN Graphene Solutions Ltd. is pleased to announce that it has made an application to change its classification on the TSX Venture Exchange from a mining issuer to an industrial, technology, life sciences issuer. Given the Company's focus on commercializing nanotechnology-enabled, next-gen healthcare solutions in the areas of prevention, detection [...]
ZEN Graphene Solutions Ltd. and is pleased to announce that Dr. Kenneth Reed, Medical Director at DermASAP, will join the ZEN Advisory Board effective immediately. Dr. Reed, a Harvard Medical School trained dermatologist, has 38 years of clinical experience in the state of Massachusetts. Dr. Reed will devote significant time and attention to [...]
ZEN Graphene Solutions Ltd. is pleased to announce that it has signed an exclusive agreement with McMaster University to be the global commercializing partner for a newly developed aptamer-based, SARS-CoV-2 rapid detection technology, developed by a team of researchers under the guidance of Drs. Yingfu Li, John Brennan and Leyla Soleymani, who are [...]
ZEN Graphene Solutions Ltd. and Trebor Rx Corp. are pleased to provide an update on the Health Canada review process for the ZEN Guard TM -enhanced, ASTM level 3 surgical mask. ZEN has been advised by Trebor that it received a response letter from Health Canada indicating that more information was required following their first full review [...]
ZEN Graphene Solutions Ltd. are pleased to announce successful inhalation safety testing results of ZENGuardTM-enhanced surgical masks and submission of these results to Health Canada. Testing was completed by NanoSafe Inc. in Blacksburg, Virginia confirmed that no ZENGuardTM graphene material was released from the surgical masks with air flow [...]
ZEN Graphene Solutions Ltd. is pleased to announce that it has developed a stable diesel fuel additive, which increased the performance of diesel fuel by up to 10% in initial testing. These tremendous early results can be improved further through additional optimization work. ZEN has filed a provisional patent for this graphene-based fuel additive [...]
ZEN Graphene Solutions Ltd. is pleased to announce that it will begin an ingestion Good Laboratory Practice compliant safety study of its patent-pending, graphene-based compound following successful testing against Clostridium Difficile at the University of Manitoba under the supervision of Dr. George Zhanel, Professor, Department of Medical [...]
ZEN Graphene Solutions Ltd. is pleased to provide an update on the following: Health Canada Submission - Additional information requested by Health Canada following the April 2 advisory has been submitted by ZEN and Trebor RX Corp Branding - Trademark application has been submitted and ZEN will begin branding and marketing of its proprietary [...]
ZEN Graphene Solutions Ltd. is pleased to announce that, effective April 8, 2021, it completed its previously announced non-brokered private placement for aggregate gross proceeds of $4,337,998, a significant increase from the $2,000,000 announced on March 25, 2021. Pursuant to the Offering, the Company issued an aggregate of 1,735,199 units at a [...]
ZEN Graphene Solutions Ltd. is aware of the statements from Health Canada regarding masks containing graphene and is aligned and supportive of the steps taken to regulate the use of graphene and remove products that are unsafe for the public. ZEN has had comprehensive testing performed on its biocidal coating and demonstrated that it can provide an [...]
ZEN Graphene Solutions Ltd. is pleased to announce, in connection with its previously announced non-brokered private placement, and previous upsizing, that due to very strong demand the Company has increased the size of the Offering to up to 2,000,000 units at a price of CDN$2.50 per Unit for gross proceeds of up to CDN$5,000,000. The private [...]
